ProCE Banner Activity

My Thoughts on New Therapeutic Strategies for Graft Versus Host Disease From TCT 2020

Clinical Thought
Review this expert perspective on key clinical findings in GVHD reported at the TCT meeting.

Released: March 16, 2020

Expiration: March 15, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Incyte

Pharmacyclics Inc

Faculty Disclosure

Primary Author

Corey Cutler, MD, MPH

Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Corey S. Cutler, MD, MPH, FRCPC, has disclosed that he has received consulting fees from Elsalys, Fresenius, Genentech, Generon, Incyte, Jazz, Kabi, Kadmon, Medsenic, Omeros, and Pharmacyclics.